Comparing the cost-effectiveness of SGLT2i versus mineralocorticoid antagonists

FHS
June 19, 2023
2:43 pm

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are approved for heart failure with reduced ejection fraction (HFrEF).

COMPASS Pathways Secures Term Loan Facility for Up to $50 Million from Hercules Capital – Psychedelic Alpha

LONDON, July 05, 2023 (GLOBE NEWSWIRE) — COMPASS Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental

July 6, 2023

Big data boosts wearable tech: New study enhances physical activity tracking

Researchers utilized a large-scale unlabeled dataset from the U.K. Biobank to train deep-learning models for accurately monitoring physical activity through wearables, demonstrating enhanced accuracy and

April 22, 2024

Launching pharmaceuticals in Belgium, the Netherlands, and Luxembourg: Opportunities and challenges – Pharmaceutical Technology

Positioned near the geographic centre of the EU, the Benelux region – comprising Belgium, the Netherlands and Luxembourg – plays a prominent role in Europe’s

September 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.